J Mol Neurosci. 2026 Nov 14;76(4):165. doi: 10.1007/s12031-026-02627-5.
ABSTRACT
Vascular dementia (VaD) is a progressive neurodegenerative disorder characterized by chronic cerebral hypoperfusion and cognitive decline, yet the role of fatty acid metabolism in its pathogenesis remains incompletely understood. Integrated transcriptomic profiling was combined with network-based analysis, weighted gene co-expression network analysis (WGCNA) and machine learning to uncover key fatty acid metabolism-associated molecular features associated with VaD. Single-cell RNA sequencing, intercellular communication inference, and in silico perturbation analyses were applied to define immune-stromal interactions. Potential therapeutic compounds were evaluated using molecular docking and dynamics simulations. We identified three VaD-related fatty acid metabolism genes (VaD-FAMRGs), namely PNPLA3, HSP90AA1, and ALB, which showed consistent diagnostic performance across multiple computational approaches and were associated with lipid metabolism, inflammatory processes, and neurovascular unit dysfunction. Functional enrichment, single-cell RNA sequencing, and in silico gene perturbation analyses provided exploratory insights into the potential associations of these candidate genes with lipid transport, metabolic regulation, synaptic maintenance, and immune-inflammatory processes. Cell-cell communication analysis further revealed activation of the ANGPTL signaling axis, suggesting impaired endothelial-glial interactions driven by lipid metabolic dysregulation. Regulatory network analysis identified key transcriptional and post-transcriptional regulators, including REST, miR-155-5p, and miR-21-5p, which may coordinately modulate VaD-FAMRG expression. Drug repurposing analysis highlighted quercetin as a candidate compound with predicted interactions with all three hub proteins, supported by molecular docking and molecular dynamics simulations. These findings suggest that dysregulated fatty acid metabolism may be associated with the development and progression of VaD through coordinated metabolic, inflammatory, and neurovascular mechanisms. This study provides a systems-level framework for understanding the underlying pathological processes and establishes a theoretical basis for future mechanistic and experimental validation.
PMID:43033318 | DOI:10.1007/s12031-026-02627-5

